Theralase Technologies Inc.
TLT.V
TSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -6.77% | 32.87% | -56.29% | 4.58% | 17.03% |
| Total Depreciation and Amortization | 8.09% | -1.98% | -7.35% | -2.20% | 2.04% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 11.70% | -16.53% | -5.13% | 59.98% | 38.99% |
| Change in Net Operating Assets | 130.80% | -134.22% | 332.26% | 130.67% | -208.52% |
| Cash from Operations | 32.52% | -205.12% | 25.83% | 67.51% | -239.20% |
| Capital Expenditure | -35.80% | 82.00% | -818.37% | 22.22% | -950.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -35.80% | 82.00% | -818.37% | 22.22% | -950.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | 0.00% | 38.96% | -104.26% | -2.17% |
| Issuance of Common Stock | -31.67% | 221.04% | -32.83% | -65.24% | 75.48% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -21.98% | 257.32% | -33.44% | -69.31% | 78.44% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 140.78% | 35.29% | -120.05% | 40.14% | -131.60% |